NCAM1 and neoplasm: The mIF staining results demonstrated that the number of CD56+ NK cells significantly increased within the tumor microenvironment in the treatment group, but there were no significant differences in the number of CD16+ NK cells (Figure 3Dp < 0.001; Figure S1C).